CU6 12.1% $7.67 clarity pharmaceuticals ltd

Ann: First patient dosed in Phase III prostate cancer trial, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,168 Posts.
    lightbulb Created with Sketch. 1834
    Imagine in the management strength and that of the CROs and partners to have the ball rolling quickly. This is the proof of the pudding.
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.